Increased take rate of human tumour xenografts after carragheenan treatment.
D000230:Adenocarcinoma / Q000648:ultrastructure; D000818:Animals; D002351:Carrageenan / Q000494:pharmacology*; D003110:Colonic Neoplasms / Q000648:ultrastructure; D006084:Graft Rejection / Q000187:drug effects*; D007165:Immunosuppression Therapy; D008264:Macrophages / Q000187:drug effects; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D008854:Microscopy, Electron; D009368:Neoplasm Transplantation; D012004:Rectal Neoplasms / Q000648:ultrastructure; D014183:Transplantation, Heterologous
D002351:Carrageenan